Press Releases :: IceCure Medical Ltd. (ICCM)

Skip to main content Skip to section navigation Skip to footer

Apr 22, 2020 8:00 am EDT

IceCure Enters German Cryoablation Oncology Market; Inks Exclusive Distribution Agreement With MTS Medical Technology

Apr 20, 2020 8:00 am EDT

IceCure Continues Global Expansion to Freeze Tumors

Apr 01, 2020 8:00 am EDT

IceCure Medical Continues Expansion in Asia; Receives Largest Purchase Order for ProSense™ Cryoablation System

Jan 07, 2020 7:00 am EST

IceCure Receives FDA Clearance for Expanded Indications of Cryoablation Technology and Regulatory Approval of New MultiSense System; Plans to Increase U.S. Presence and Operations

Dec 02, 2019 9:26 am EST

IceCure Medical Appoints Medical Device Veteran Sharon Levita to its Board of Directors

Aug 05, 2019 8:00 am EDT

Another Success: IceCure Receives Israeli AMAR Approval for Use of its Freezing Technology in Specific Indications, Following an Earlier General Approval

Jul 02, 2019 8:00 am EDT

IceCure Medical Announces New Category III CPT Code for Breast Cryoablation Therapy, Issued by the American Medical Association

Mar 20, 2019 8:00 am EDT

IceCure Medical Presents Promising Results from First-ever Interventional Radiology Study With Its Next Generation Liquid Nitrogen (LN2) Cryoablation System, ProSense™

Feb 05, 2019 7:30 am EST

Recent American Society of Breast Surgeons (ASBrS) Guidelines are Favorable to Next Generation Cryoablation Developer, IceCure Medical

May 01, 2014 4:08 pm EDT

IceCure Medical, Inc. announces commencement of ICE3 clinical trial for breast cancer

Select a page:

rss_feed News RSS

IceCure Medical HQ: 7 Ha’Eshel St., PO Box 3163, Caesarea, 3079504, Israel

© 2023 All Rights Reserved IceCure Medical

Branding by

Terms of Use | Privacy | Last Updated: April 9, 2023